Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MET | P08581 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9891 | 1.00 | TSHR (0.40) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL641967 | 1.00 | TSHR (0.40) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL4964887 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL7359458 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL7924907 | 0.97 | OPRM1 (0.39) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL5081429 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL7572979 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL3711846 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL3708728 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL541617 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0990634-B1 | ACYLATING AGENTS, ACYLATION METHOD WITH THE USE OF THE SAME AND ADAMANTANE DERIVATIVES | DAICEL CHEM (JP) | 2013-04-10 | — | — | EP | disclosed |
| EP-1055654-B1 | PROCESS FOR THE PREPARATION OF ORGANIC COMPOUNDS WITH IMIDE CATALYSTS | DAICEL CHEM (JP) | 2008-02-20 | — | — | EP | disclosed |
| US-7183423-B1 | Process for the preparation of organic compounds with imide catalysts | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-02-27 | — | — | US | disclosed |
| CN-1211333-C | Alicyclic compounds containing hydroxymethyl group, process for producing the same, and polymerizable alicyclic compound | DAICCL CHEMICAL IND LTD (JP) | 2005-07-20 | — | — | CN | disclosed |
| US-6576787-B1 | Hydroxymethyl-group-containing alicyclic compound and process for producing the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-06-10 | — | — | US | disclosed |
| US-20030032806-A1 | Oxidation of carbon-boron bonds | CAI WEILING (US) | 2003-02-13 | — | — | US | disclosed |
| US-6429314-B1 | USING 1,2-DICARBONYL DERIVATIVE OR ITS HYDROXY REDUCTIVE, OXYGEN, COBALT ACETATE METAL COMPOUND, AND N-HYDROXYPHTHALIMIDE OR OTHER IMIDE DERIVATIVE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-08-06 | — | — | US | disclosed |
| US-20020049352-A1 | Oxidation of carbon-boron bonds | CAI WEILING (US) | 2002-04-25 | — | — | US | disclosed |
| EP-1167329-A2 | Oxidation of carbon-boron bonds | Pfizer Products Inc. (US) | 2002-01-02 | — | — | EP | disclosed |
| CN-1293649-A | Hydroxymethyl-containing alicyclic compound, process for producing the same, and polymerizable alicyclic compound | OAICAL CHEMIAL IND LTD (JP) | 2001-05-02 | — | — | CN | disclosed |
| US-6218569-B1 | CATALYTIC ESTERIFICATION REACTION OF ALICYCLIC ALCOHOL AND UNSATURATED CARBOXYLIC ACID; PHOTOSENSITIVITY | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2001-04-17 | — | — | US | disclosed |
| EP-1070699-A1 | ALICYCLIC COMPOUNDS CONTAINING HYDROXYMETHYL GROUP, PROCESS FOR PRODUCING THE SAME, AND POLYMERIZABLE ALICYCLIC COMPOUND | Daicel Chemical Industries, Ltd. (JP) | 2001-01-24 | — | — | EP | disclosed |
| EP-1057806-A1 | POLYMERIZABLE ALICYCLIC ESTERS AND PROCESS FOR PRODUCING THE SAME | Daicel Chemical Industries, Ltd. (JP) | 2000-12-06 | — | — | EP | disclosed |
| EP-1055654-A1 | PROCESS FOR THE PREPARATION OF ORGANIC COMPOUNDS WITH IMIDE CATALYSTS | Daicel Chemical Industries, Ltd. (JP) | 2000-11-29 | — | — | EP | disclosed |
| EP-0990634-A1 | ACYLATING AGENTS, ACYLATION METHOD WITH THE USE OF THE SAME AND ADAMANTANE DERIVATIVES | Daicel Chemical Industries, Ltd. (JP) | 2000-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032806-A1 | Oxidation of carbon-boron bonds | CYBB, FOSB, SCO2 | TSHR 4484/4885OPRM1 1366/4885OPRK1 1134/4885 |
| US-20020049352-A1 | Oxidation of carbon-boron bonds | CYBB, FOSB, SCO2 | TSHR 4484/4885OPRM1 1366/4885OPRK1 1134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.